Lv1
20 积分 2021-04-24 加入
962 A novel CD2-targeted costimulatory bispecific antibody platform for enhancing CD3 T cell engager-based cancer immunotherapy
2天前
已完结
Pan-cancer single-cell landscape of tumor-infiltrating T cells
2天前
已完结
Artificial intelligence in drug development
1个月前
已完结
Antigen-specific profiling identifies T-bet+ melanoma-specific CD8+ T cells associated with response to neoadjuvant PD-1 blockade
1个月前
已完结
Antigen-specific profiling identifies T-bet+ melanoma-specific CD8+ T cells associated with response to neoadjuvant PD-1 blockade
2个月前
已完结
A trispecific antibody engaging T cells with tumour and myeloid cells augments antitumour immunity
2个月前
已完结
Development and Characterization of a Lysosome-Targeting SLC3A2/PD-L1 Bispecific Antibody-Drug Conjugate for Enhanced Anti-Tumor Efficacy in Solid Tumors
4个月前
已完结
ABBV-303 is a Natural Killer Cell Engager Specific for c-Met-Expressing Tumors
4个月前
已完结
Abstract 344: IBI3014, a TROP2xPD-L1 bi-specific ADC integrating ADC killing with checkpoint blockade within one molecule, exhibits promising efficacy and safety in preclinical models
4个月前
已关闭
Detection and quantitation of eosinophils in the murine respiratory tract by flow cytometry
4个月前
已完结
皖公网安备34019202002308
